Exact Mass: 337.0751

Exact Mass Matches: 337.0751

Found 51 metabolites which its exact mass value is equals to given mass value 337.0751, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

5-Hydroxymethyldeoxycytidylate

5-Hydroxymethyldeoxycytidylate; 5-Hydroxymethyldeoxycytidylic acid; 2-Deoxy-5-hydroxymethylcytidine 5-phosphate

C10H16N3O8P (337.0675)


   

2,8-Dihydroxyquinoline-beta-D-glucuronide

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(8-hydroxyquinolin-2-yl)oxy]oxane-2-carboxylic acid

C15H15NO8 (337.0798)


2,8-Dihydroxyquinoline-beta-D-glucuronide is a glucuronide conjugate of 2,8-Dihydroxyquinoline. 2,8-Dihydroxyquinoline is an intermediate in gut microbial metabolism of quinoline or 8-hydroxyquinoline. Quinoline is also used as a catalyst, a corrosion inhibitor, in metallurgical processes, in the manufacture of dyes, as a preservative for anatomical specimens, in polymers and agricultural chemicals, and as a solvent for resins and terpenes. It is also used as an antimalarial medicine. 2,8-Dihydroxyquinoline-beta-D-glucuronide has been identified as a potential urinary biomarker that is elevated by peroxisome proliferator-activated receptor (PPARalpha) agonists. (PMID: 17550978) [HMDB] 2,8-Dihydroxyquinoline-beta-D-glucuronide is a glucuronide conjugate of 2,8-Dihydroxyquinoline. 2,8-Dihydroxyquinoline is an intermediate in gut microbial metabolism of quinoline or 8-hydroxyquinoline. Quinoline is also used as a catalyst, a corrosion inhibitor, in metallurgical processes, in the manufacture of dyes, as a preservative for anatomical specimens, in polymers and agricultural chemicals, and as a solvent for resins and terpenes. It is also used as an antimalarial medicine. 2,8-Dihydroxyquinoline-beta-D-glucuronide has been identified as a potential urinary biomarker that is elevated by peroxisome proliferator-activated receptor (PPARalpha) agonists. (PMID: 17550978).

   

3-Indole carboxylic acid glucuronide

(3S,4S,5R,6S)-3,4,5-trihydroxy-6-(1H-indole-3-carbonyloxy)oxane-2-carboxylic acid

C15H15NO8 (337.0798)


3-Indole carboxylic acid glucuronide is a natural human metabolites of Indole-3-carboxylic acid. Indole-3-carboxylic acid is a normal urinary indolic tryptophan metabolite (PMID 4844607) and has been found elevated in patients with liver diseases (PMID 13905029). Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. [HMDB] 3-Indole carboxylic acid glucuronide is a natural human metabolites of Indole-3-carboxylic acid. Indole-3-carboxylic acid is a normal urinary indolic tryptophan metabolite (PMID 4844607) and has been found elevated in patients with liver diseases (PMID 13905029). Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys.

   

Ezutromid

5-(Ethanesulphonyl)-2-(naphthalen-2-yl)-1,3-benzoxazole

C19H15NO3S (337.0773)


C78281 - Agent Affecting Musculoskeletal System

   

Maybridge1_001727

Maybridge1_001727

C16H13F2NO5 (337.0762)


   

Maybridge3_005321

Maybridge3_005321

C17H12ClN5O (337.073)


   

O1-(2-Hydroxy-[6]chinolyl)-beta-D-glucopyranuronsaeure|O1-(2-hydroxy-[6]quinolyl)-beta-D-glucopyranuronic acid

O1-(2-Hydroxy-[6]chinolyl)-beta-D-glucopyranuronsaeure|O1-(2-hydroxy-[6]quinolyl)-beta-D-glucopyranuronic acid

C15H15NO8 (337.0798)


   

O1-(4-Hydroxy-[6]chinolyl)-beta-D-glucopyranuronsaeure|O1-(4-hydroxy-[6]quinolyl)-beta-D-glucopyranuronic acid

O1-(4-Hydroxy-[6]chinolyl)-beta-D-glucopyranuronsaeure|O1-(4-hydroxy-[6]quinolyl)-beta-D-glucopyranuronic acid

C15H15NO8 (337.0798)


   

O1-(4-Hydroxy-[3]chinolyl)-beta-D-glucopyranuronsaeure|O1-(4-hydroxy-[3]quinolyl)-beta-D-glucopyranuronic acid

O1-(4-Hydroxy-[3]chinolyl)-beta-D-glucopyranuronsaeure|O1-(4-hydroxy-[3]quinolyl)-beta-D-glucopyranuronic acid

C15H15NO8 (337.0798)


   

O1-(2-Hydroxy-[4]chinolyl)-beta-D-glucopyranuronsaeure|O1-(2-hydroxy-[4]quinolyl)-beta-D-glucopyranuronic acid

O1-(2-Hydroxy-[4]chinolyl)-beta-D-glucopyranuronsaeure|O1-(2-hydroxy-[4]quinolyl)-beta-D-glucopyranuronic acid

C15H15NO8 (337.0798)


   

2,8-Dihydroxyquinoline-b-D-glucuronide

2,8-Dihydroxyquinoline-beta-delta-glucuronide

C15H15NO8 (337.0798)


   

n-(8-bromooctyl)phthalimide

n-(8-bromooctyl)phthalimide

C16H20BrNO2 (337.0677)


   

2-cyano-2-[2,3-dihydro-3-(tetrahydro-2,4,6-trioxo-5(2H)-pyrimidinylidene)-1H-isoindol-1-ylidene]-N-methylacetamide

2-cyano-2-[2,3-dihydro-3-(tetrahydro-2,4,6-trioxo-5(2H)-pyrimidinylidene)-1H-isoindol-1-ylidene]-N-methylacetamide

C16H11N5O4 (337.0811)


   

5-Hydroxymethyl-2’-deoxycytidine

5-Hydroxymethyl-2’-deoxycytidine

C10H16N3O8P (337.0675)


   

tert-butyl 1-(4-bromophenyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate

tert-butyl 1-(4-bromophenyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate

C16H20BrNO2 (337.0677)


   

(Cyanomethyl)(triphenyl)phosphonium chloride

(Cyanomethyl)(triphenyl)phosphonium chloride

C20H17ClNP (337.0787)


   

(5-bromo-1H-indol-3-yl) octanoate

(5-bromo-1H-indol-3-yl) octanoate

C16H20BrNO2 (337.0677)


   

3-(4-FLUORO-PHENYL)-3-(TOLUENE-4-SULFONYLAMINO)-PROPIONIC ACID

3-(4-FLUORO-PHENYL)-3-(TOLUENE-4-SULFONYLAMINO)-PROPIONIC ACID

C16H16FNO4S (337.0784)


   

Intrazole

(4-chlorophenyl)-[3-(2H-tetrazol-5-ylmethyl)indol-1-yl]methanone

C17H12ClN5O (337.073)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

UNC669

(5-Bromopyridin-3-yl)(4-(pyrrolidin-1-yl)piperidin-1-yl)methanone

C15H20BrN3O (337.079)


   
   

ETHYL 3-(4-CHLOROANILINE)-2-(2,5-DIOXOTETRAHYDROFURAN-3-YL)BUT-2-ENOATE

ETHYL 3-(4-CHLOROANILINE)-2-(2,5-DIOXOTETRAHYDROFURAN-3-YL)BUT-2-ENOATE

C16H16ClNO5 (337.0717)


   

(dimethyl)[3-thieno[2,3-c][2]benzothiepin-4(9H)-ylidenepropyl]ammonium chloride

(dimethyl)[3-thieno[2,3-c][2]benzothiepin-4(9H)-ylidenepropyl]ammonium chloride

C17H20ClNS2 (337.0726)


   

4-(4-ethoxyanilino)-3-nitrobenzenesulfonamide

4-(4-ethoxyanilino)-3-nitrobenzenesulfonamide

C14H15N3O5S (337.0732)


   

2-[3-(5-Mercapto-[1,3,4]thiadiazol-2-YL)-ureido]-N-methyl-3-phenyl-propionamide

2-[3-(5-Mercapto-[1,3,4]thiadiazol-2-YL)-ureido]-N-methyl-3-phenyl-propionamide

C13H15N5O2S2 (337.0667)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D061965 - Matrix Metalloproteinase Inhibitors

   

5-Methylcytidine 5-monophosphate

5-Methylcytidine 5-monophosphate

C10H16N3O8P (337.0675)


   

9-(5,5-Difluoro-5-phosphonopentyl)guanine

9-(5,5-Difluoro-5-phosphonopentyl)guanine

C10H14F2N5O4P (337.0751)


   

2-O-methylcytidine 5-monophosphate

2-O-methylcytidine 5-monophosphate

C10H16N3O8P (337.0675)


   

3-[(4-Fluorophenyl)methylthio]-6-pyridin-4-yl-[1,2,4]triazolo[4,3-b]pyridazine

3-[(4-Fluorophenyl)methylthio]-6-pyridin-4-yl-[1,2,4]triazolo[4,3-b]pyridazine

C17H12FN5S (337.0797)


   

Phenacyl 2-quinolin-8-ylsulfanylacetate

Phenacyl 2-quinolin-8-ylsulfanylacetate

C19H15NO3S (337.0773)


   

2-[[5-(2-Chlorophenyl)-1,3,4-oxadiazol-2-yl]thio]-1-(1-piperidinyl)ethanone

2-[[5-(2-Chlorophenyl)-1,3,4-oxadiazol-2-yl]thio]-1-(1-piperidinyl)ethanone

C15H16ClN3O2S (337.0652)


   

3-Ethyl-6-{[(4-Fluorophenyl)sulfonyl]amino}-2-Methylbenzoic Acid

3-Ethyl-6-{[(4-Fluorophenyl)sulfonyl]amino}-2-Methylbenzoic Acid

C16H16FNO4S (337.0784)


   

Glutathione sulfinamide

Glutathione sulfinamide

C10H17N4O7S- (337.0818)


   
   

N-[(3-nitrophenyl)methylideneamino]-4-oxo-1H-quinazoline-2-carboxamide

N-[(3-nitrophenyl)methylideneamino]-4-oxo-1H-quinazoline-2-carboxamide

C16H11N5O4 (337.0811)


   

N-methyl-2-[[4-methyl-5-[(4-nitrophenoxy)methyl]-1,2,4-triazol-3-yl]thio]acetamide

N-methyl-2-[[4-methyl-5-[(4-nitrophenoxy)methyl]-1,2,4-triazol-3-yl]thio]acetamide

C13H15N5O4S (337.0845)


   

N(3)-methylcytidine 5-monophosphate

N(3)-methylcytidine 5-monophosphate

C10H16N3O8P (337.0675)


   

N-(2-adamantyl)-4-bromo-1-methyl-3-pyrazolecarboxamide

N-(2-adamantyl)-4-bromo-1-methyl-3-pyrazolecarboxamide

C15H20BrN3O (337.079)


   

3-[1-(4-Chlorophenyl)-5-tetrazolyl]-1-methyl-4-quinolinone

3-[1-(4-Chlorophenyl)-5-tetrazolyl]-1-methyl-4-quinolinone

C17H12ClN5O (337.073)


   

2-methyl-6-[(5-phenylthiophene-2-carbonyl)amino]benzoic Acid

2-methyl-6-[(5-phenylthiophene-2-carbonyl)amino]benzoic Acid

C19H15NO3S (337.0773)


   

3-bromo-2-heptyl-1-hydroxy-4(1H)-quinolinone

3-bromo-2-heptyl-1-hydroxy-4(1H)-quinolinone

C16H20BrNO2 (337.0677)


   

N(4)-methylcytidine 5-monophosphate

N(4)-methylcytidine 5-monophosphate

C10H16N3O8P (337.0675)


   

N-[2-(uran-2-ylmethylsulanyl)ethyl]-2-(3-methoxyphenyl)sulanylacetamide

N-[2-(uran-2-ylmethylsulanyl)ethyl]-2-(3-methoxyphenyl)sulanylacetamide

C16H19NO3S2 (337.0806)


   

1-O-(1H-indol-3-ylcarbonyl)-beta-D-glucopyranuronic acid

1-O-(1H-indol-3-ylcarbonyl)-beta-D-glucopyranuronic acid

C15H15NO8 (337.0798)


   

5-Hydroxymethyldeoxycytidylic acid

5-Hydroxymethyldeoxycytidylic acid

C10H16N3O8P (337.0675)


   

2,8-Dihydroxyquinoline-beta-D-glucuronide

2,8-Dihydroxyquinoline-beta-D-glucuronide

C15H15NO8 (337.0798)


   

3-Indole carboxylic acid glucuronide

3-Indole carboxylic acid glucuronide

C15H15NO8 (337.0798)


An O-acyl carbohydrate obtained by formal condensation of the carboxy group of indole-3-carboxylic acid with the anomeric hydroxy group of beta-D-glucuronic acid.

   

PSB-12062

PSB-12062

C19H15NO3S (337.0773)


PSB-12062 is a potent and selective P2X4 antagonist with an IC50 of 1.38 μM for human P2X4.

   

TRC160334

TRC160334

C14H15N3O5S (337.0732)


TRC160334 is a hypoxia-inducible factor (HIF) hydroxylase inhibitor. TRC160334 can be used for the research of ischemia/reperfusion injury[1].

   

({5'-bromo-4-methoxy-1h,1'h-[2,2'-bipyrrol]-5-yl}methylidene)(2-methylbutyl)amine

({5'-bromo-4-methoxy-1h,1'h-[2,2'-bipyrrol]-5-yl}methylidene)(2-methylbutyl)amine

C15H20BrN3O (337.079)


   

(2s,3r,4s,5s,6r)-2-{[(2r,3r,6z)-3-hydroxy-6-(methoxyimino)-2,3-dihydrothiopyran-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(2r,3r,6z)-3-hydroxy-6-(methoxyimino)-2,3-dihydrothiopyran-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C12H19NO8S (337.0831)